Skip to content

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated in Healthy Subjects and Patients With Frontotemporal Dementia. Pilot Phase.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02496312
Acronym
ECOCAPTURE
Enrollment
14
Registered
2015-07-14
Start date
2015-07-10
Completion date
2015-10-02
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apathy, Behavior, Frontotemporal Dementia

Keywords

Apathy, Goal-directed behavior, Quantitative evaluation, Sensor, Ethogram

Brief summary

The purpose of this study is to provide relevant quantitative evaluation of apathy close to real life situation by means of a multimodal sensor system integrated.

Detailed description

The investigators try to measure the amount of goal-directed behaviour and to detect the pattern of apathy. The main objective of this pilot phase is to select the variables of goal-directed behaviour from the list of metrics providing by the multimodal acquisition system in healthy subjects and patients with frontotemporal dementia.

Interventions

BEHAVIORALEvaluation of Apathy Close to Real Life Situation

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of Frontotemporal Dementia (FTD) according to diagnostic criteria reported by Rascovsky et al. (2011). * Understanding of the instructions and capacity to realize the cognitive tasks. * Capacity to read, to understand and to sign legal document of information * Capacity for informed consent for research, capacity to sign consent * MMSE score \> 20 * Absence of other cerebral pathology. * Absence of psychiatric disease interfering with the assessment of the tests * Absence of excessive psychotropic use * Access to National Healthcare Insurance * Accompanied with a caregiver

Exclusion criteria

* Excessive psychotropic use * Incapacity or refusal to realize the experimental tasks * Subject deprived of freedom by an administrative or court order * Subject under legal protective measure. * Incapacity for informed consent for research * Participation in another biomedical research * Airway obstruction risk * Reduction of activity not attributable to another chronic pathological condition

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of each behavior from the ethogram45 min\[Provided by the video recording and The Observer NOLDUS software\]
Frequency of each behavior from the ethogram45 min\[Provided by the video recording and The Observer NOLDUS software\]
Duration of each behavior from the ethogram45 mn\[Provided by the video recording and The Observer NOLDUS software\]
Number of different behaviors45 mn\[Provided by the video recording and The Observer NOLDUS software\]
Activity classes45 mn\[Provided by the MOVE MOVISENS sensor\] lying, sitting, ...
Body positions45 mn\[Provided by the MOVE MOVISENS sensor\] lying left, ...
Energy expenditure45 mn\[Provided by the MOVE MOVISENS sensor\] kcal.
MET45 mn\[Provided by the MOVE MOVISENS sensor\] The Metabolic Equivalent of Task. MET level.
Steps45 mn\[Provided by the MOVE MOVISENS sensor\] Counting steps.
Activity intensity45 mn\[Provided by the MOVE MOVISENS sensor\] g.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORRichard LEVY, PhD, MD

INSERM UMR_S 1127, ICM

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026